# EDGAR Filing Document

**Accession Number:** 0001809616
**File Stem:** 0001213900-25-080750
**Filing Date:** 2025-8
**Character Count:** 2666
**Document Hash:** 5d5340043c874c249b56b77a3021cca6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-080750.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001213900-25-080750

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250826

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Universe Pharmaceuticals INC
- **CENTRAL INDEX KEY:** 0001809616
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** F4
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40231
- **FILM NUMBER:** 251257608

**BUSINESS ADDRESS:**
- **STREET 1:** 265 JINGJIU AVENUE
- **STREET 2:** JINGGANGSHAN ECON. AND TECH. DEV. ZONE
- **CITY:** JI'AN, JIANGXI
- **STATE:** F4
- **ZIP:** 343100
- **BUSINESS PHONE:** 86-0796-8403309

**MAIL ADDRESS:**
- **STREET 1:** 265 JINGJIU AVENUE
- **STREET 2:** JINGGANGSHAN ECON. AND TECH. DEV. ZONE
- **CITY:** JI'AN, JIANGXI
- **STATE:** F4
- **ZIP:** 343100

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER** 

**PURSUANT TO RULE 13a-16 OR 15d-16** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of August 2025**

**Commission file number: 001-40231**

**Universe Pharmaceuticals INC**

**265 Jingjiu Avenue**

**Jinggangshan Economic and Technological Development Zone**

**Ji'an, Jiangxi, China 343100**

**+86-0796-8403309**

**(Address of principal executive offices)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**Adjournment of Annual General Meeting**

On August 26, 2025, Universe Pharmaceuticals INC (the "Company") convened the 2025 annual general meeting of shareholders (the "2025 Annual General Meeting"). However, due to a lack of quorum, the 2025 Annual General Meeting was adjourned to September 2, 2025, at 10:00 a.m., Beijing Time at 265 Jingjiu Avenue, Jinggangshan Economy and Technology Development Zone, Ji'an City, Jiangxi 343100, the People's Republic of China.

**SIGNATURES**

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Universe Pharmaceuticals INC. | Universe Pharmaceuticals INC. |
| Date: August 26, 2025 | By: | /s/ Gang Lai |
|  |  | Gang Lai |
|  |  | Chief Executive Officer |

---